Bob Herman
Coverage of Bob Herman in the Nexus archive.
- STAT+: A suspicious denial pattern in Medicare Advantage
Casey Ross and Bob Herman report that large Medicare Advantage insurers used artificial intelligence to override clinicians' judgments, denying care to seriously ill older and disabled patients. The article highlights a suspicious pattern of denied care in Medicare Advantage plans.
- STAT+: Why the WakeMed – Atrium Health hospital merger matters
A hospital system merger in North Carolina has created local controversy but has national relevance. The merger is between WakeMed and Atrium Health. This event may have broader implications for the healthcare industry.
- STAT+: Medicare’s miss on Alzheimer’s drug spending
Medicare's predicted spending on Alzheimer's drug Leqembi was $3.5 billion in 2025, but the actual cost is expected to be higher. The prediction was made by Medicare's actuaries two years ago. The article discusses the discrepancy in the predicted and actual costs.